Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Not yet taking people in ChinaIBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer
- Where
- Zhengzhou
- Age
- 18 years to 75 years
- People
- 50
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07361991 - No phaseEnrolling by invitationProlonged Extubation in Gastric Cancer With OSA
- Where
- Jinan
- Age
- 18 years to 85 years
- People
- 240
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07362706 - Phase 2Taking peopleRadiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 100
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT05978193 - Phase 3Taking peopleJS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
- Where
- Anyang, Baotou, Beijing, Binzhou, Changchun, Changsha, Chengdu, Datong, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Ji'nan, Jinan, Kunming, Langfang, Lanzhou, Linfen, Linyi, Luoyang, Meizhou, Nanchang, Nanjing, Nanning, Nanyang, Puyang, Qingdao, Sanmenxia, Shanghai, Shantou, Shenyang, Shijiazhuang, Suining, Taiyuan, Tangshan, Ürümqi, Weifang, Wenzhou, Wuhan, Wuwei, Wuxi, Xi’an, Xiangyang, Xuzhou, Yangzhou, Yibin, Yichang, Yinchuan, Zhengzhou, Zhoukou
- Age
- 18 years and over
- People
- 560
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT07284134 - No phaseTaking peopleLaryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
- Where
- Hangzhou
- People
- 1,200
- Run by
- Zhejiang University
See details and how to joinNCT07359586 - Phase 3Taking peopleChemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
- Where
- Anyang, Beijing, Changsha, Nanjing
- Age
- 18 years and over
- People
- 2,000
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT04821778 - Phase 3Taking peopleNeoadjuvant Treatment Modalities in Esophageal Cancer
- Where
- Beijing
- Age
- 18 years and over
- People
- 2,000
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT04821843 - Phase 2Not yet taking people in ChinaSynergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 79 years
- People
- 84
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06468280 - Phase 1/2Taking peopleA First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
- Where
- Beijing
- Age
- 18 years and over
- People
- 170
- Run by
- 3H Pharmaceuticals Co., Ltd.
See details and how to joinNCT07354711 - Early phase 1Enrolling by invitationClinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 100
- Run by
- Fujian Medical University
See details and how to joinNCT07356466 - Phase 3Taking peopleStudy to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
- Where
- Beijing
- Age
- 18 years and over
- People
- 550
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT04342910 - No phaseTaking peoplePrecision Palliative Care for Patients With Advanced Esophageal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 624
- Run by
- Fudan University
See details and how to joinNCT06787313 - Phase 1Taking peopleA Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
- Where
- Hangzhou, Shanghai, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Phrontline Biopharma
See details and how to joinNCT07181473 - Phase 3Not yet taking people in ChinaRobotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 335
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07331454 - Phase 1/2Not yet taking people in ChinaA Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07333573 - Phase 1/2Taking peopleFruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
- Where
- Zhengzhou
- Age
- 18 years to 75 years
- People
- 45
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07334431 - Phase 2Taking peopleA Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
- Where
- Hangzhou, Shijiazhuang
- Age
- 18 years to 70 years
- People
- 200
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07110571 - Phase 2Not yet taking people in ChinaSpirulina Derivative for Radiation Esophagitis
- Where
- Chengdu
- Age
- 18 years and over
- People
- 70
- Run by
- West China Hospital
See details and how to joinNCT07324018 - Phase 2Taking peoplePerioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT07325630 - Phase 3Taking peopleTDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 432
- Run by
- Fudan University
See details and how to joinNCT06676449 - Phase 1/2Taking peopleHypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
- Where
- Chengdu, Xiamen
- Age
- 18 years and over
- People
- 84
- Run by
- West China Hospital
See details and how to joinNCT07182565 - Phase 2Taking peopleIparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 32
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07315854 - Phase 1Taking peopleNeoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
- Where
- Shanghai
- Age
- 18 years and over
- People
- 60
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07317609 - Phase 3Not yet taking people in ChinaClinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 118
- Run by
- Fujian Medical University
See details and how to joinNCT07314203 - Phase 2Not yet taking people in ChinaQL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 74
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07315035